BioCorRx (BICX) Change in Receivables (2011 - 2026)
BioCorRx (BICX) posted Change in Receivables of $76889.0 for Q1 2026, down 82.83% sequentially from $447901.0 in Q4 2025, and down 31.33% YoY from $111966.0 in Q1 2025.
Powered by 
Analysis
BioCorRx (BICX) Change in Receivables (2011 - 2026) Analysis & Trends
BioCorRx has reported Change in Receivables for 16 years, with the latest figure at $76889.0 in Q1 2026.
- Quarterly Change in Receivables fell 31.33% year-over-year to $76889.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $218382.0 (up 97.66% YoY) and the FY2025 annual result came in at $253459.0, up 34351.22% from the prior year.
- Change in Receivables fell to $76889.0 in Q1 2026 per BICX's latest filing, from $447901.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $447901.0 in Q4 2025 and troughed at -$245684.0 in Q3 2025.
- A 5-year average of $21923.2 and a median of $2572.0 in 2022 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables surged 19714.0% in 2022, then plunged 4002.97% in 2025.
- Over 5 years, Change in Receivables stood at $99070.0 in 2022, then sank by 158.34% to -$57801.0 in 2023, then soared by 97.44% to -$1480.0 in 2024, then soared by 30363.58% to $447901.0 in 2025, then plunged by 82.83% to $76889.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $76889.0, $447901.0, and -$245684.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | 954.00 Mn |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | 5.00 Mn |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | 10.20 Mn |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | -5.55 Mn |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | 14.05 Mn |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 5.61 Mn |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | -26.18 Mn |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | -13.54 Mn |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 3.35 Mn |
| 10 | BioCorRx | 3.46 Mn | 3.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 76,889.00 |
| Dec 31, 2025 | 447,901.00 |
| Sep 30, 2025 | -245,684.00 |
| Jun 30, 2025 | -60,724.00 |
| Mar 31, 2025 | 111,966.00 |
| Jun 30, 2024 | -1,480.00 |
| Mar 31, 2024 | 740.00 |
| Dec 31, 2023 | -57,801.00 |
| Sep 30, 2023 | 45,888.00 |
| Jun 30, 2023 | -45,888.00 |
| Mar 31, 2023 | 23,163.00 |
| Dec 31, 2022 | 99,070.00 |
| Sep 30, 2022 | -76,657.00 |
| Jun 30, 2022 | 2,572.00 |
| Mar 31, 2022 | 8,893.00 |
| Dec 31, 2021 | 500.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | -500.00 |
| Dec 31, 2020 | -500.00 |
| Jun 30, 2020 | -185,918.00 |